MSACL Conference Schedule

The Application of a Metabolomics Dataset Toward the Understanding of Prostate Cancer
Tue 3:30 PM - Session: Metabolomics
Chris Beecher
A metabolomic study of Clinical Prostate biopsies, plasma, and urines has revealed a novel biomarker of prostate cancer and given insight into metastatic cancer progression. Specifically, the compound sarcosine was shown to be highly correlated with cancer development. A number of additional studies have revealed some interesting biological connections.